Teva Stock Gains. The Company Will Divest Drug Ingredients Business.
Teva has struggled for years with enormous debts and litigation over its role in the opioid crisis.
Source: marketwatch.com
Stay updated with breaking news from Eapi Fr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva has struggled for years with enormous debts and litigation over its role in the opioid crisis.
By Helena Smolak Euroapi shares hit a new record low on Tuesday after the company cut its sales growth forecast for 2023 and suspended its medium-term...
By Pierre Bertrand Euroapi downgraded its outlook for the year and said it is launching a strategic review to adapt its operating model after a slowdown in...